Impact of nisin on Clostridioides difficile and microbiota composition in a faecal fermentation model of the human colon

被引:12
|
作者
O'Reilly, Catherine [1 ,2 ,3 ]
O'Connor, Paula M. [1 ,3 ]
O'Sullivan, Orla [1 ,3 ]
Rea, Mary C. [1 ,3 ]
Hill, Colin [2 ,3 ]
Ross, R. Paul [1 ,2 ,3 ]
机构
[1] Teagasc Food Res Ctr, Moorepk, Fermoy, Cork, Ireland
[2] Univ Coll Cork, Sch Microbiol, Cork, Ireland
[3] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland
关键词
16S rRNA gene sequencing; C; difficile; ex vivo faecal fermentation; nisin; INTESTINAL MICROBIOTA; NARROW-SPECTRUM; BACTERIOCIN; RISK; ANTIBIOTICS; THERAPIES; DIVERSITY; INFECTION; PREGNANCY; DIARRHEA;
D O I
10.1111/jam.15250
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aims Nisin is a bacteriocin with a broad spectrum of activity against Gram-positive bacteria. The aims were to assess nisin activity against Clostridioides difficile in a complex microbial environment and determine the minimum inhibitory concentration at which C. difficile growth is suppressed whilst having minimal impact on the faecal microbiota. Methods and Results Faecal slurries were prepared from fresh faecal samples and spiked with C. difficile (10(6) CFU per ml). Nisin was added to each fermentation at a range of concentrations from 0 to 500 mu M. Following 24 h, 16S rRNA gene sequencing was performed, and the presence of viable C. difficile was assessed. There was no viable C. difficile detected in the presence of 50-500 mu M nisin. There was a decrease in the diversity of the microbiota in a nisin dose-dependent manner. Nisin predominantly depleted the relative abundance of the Gram-positive bacteria whilst the relative abundance of Gram-negative bacteria such as Escherichia Shigella and Bacteroides increased. Conclusions Using an ex vivo model of the colon, this study demonstrates the ability of purified nisin to selectively deplete C. difficile in a faecal microbial environment and establishes the minimum concentration at which this occurs whilst having a minimal impact on the composition of the microbiota. Significance and Impact of the Study This study opens up the potential to use nisin as a therapeutic for clostridial gut infections.
引用
收藏
页码:1397 / 1408
页数:12
相关论文
共 50 条
  • [1] Faecal microbiota transplantation for Clostridioides difficile infection
    Waldbaum, Carlos
    Lopez, Fabiana
    Antelo, Pablo
    Sorda, Juan
    [J]. MEDICINA-BUENOS AIRES, 2020, 80 (06) : 633 - 639
  • [2] Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology
    Alexander Khoruts
    Christopher Staley
    Michael J. Sadowsky
    [J]. Nature Reviews Gastroenterology & Hepatology, 2021, 18 : 67 - 80
  • [3] Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection
    Jillian R.-M. Brown
    Burkhardt Flemer
    Susan A. Joyce
    Akbar Zulquernain
    Donal Sheehan
    Fergus Shanahan
    Paul W. O’Toole
    [J]. BMC Gastroenterology, 18
  • [4] Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection
    Brown, Jillian R. -M.
    Flemer, Burkhardt
    Joyce, Susan A.
    Zulquernain, Akbar
    Sheehan, Donal
    Shanahan, Fergus
    O'Toole, Paul W.
    [J]. BMC GASTROENTEROLOGY, 2018, 18
  • [5] The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection
    Goldenberg, Simon D.
    Merrick, Blair
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [6] Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection
    Krutova, Marcela
    Davis, Kerrie
    Guery, Benoit
    Barbut, Frederic
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (02): : 111 - 112
  • [7] Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection Reply
    Baunwall, Simon Mark Dahl
    Andreasen, Sara Ellegaard
    Hansen, Mette Mejlby
    Kelsen, Jens
    Hoyer, Katrine Lundby
    Ragard, Nina
    Eriksen, Lotte Lindgreen
    Stoy, Sidsel
    Rubak, Tone
    Damsgaard, Else Marie Skjode
    Mikkelsen, Susan
    Erikstrup, Christian
    Dahlerup, Jens Frederik
    Hvas, Christian Lodberg
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (02): : 112 - 113
  • [8] The Regulatory Approach for Faecal Microbiota Transplantation as Treatment for Clostridioides difficile Infection in Italy
    de Stefano, Maria Chiara
    Mazzanti, Benedetta
    Vespasiano, Francesca
    Lombardini, Letizia
    Cardillo, Massimo
    [J]. ANTIBIOTICS-BASEL, 2022, 11 (04):
  • [9] Adaptation mechanisms of Clostridioides difficile to auranofin and its impact on human gut microbiota
    Anjou, Cyril
    Royer, Marie
    Bertrand, Emilie
    Bredon, Marius
    Le Bris, Julie
    Salgueiro, Iria Alonso
    Caulat, Leo C.
    Dupuy, Bruno
    Barbut, Frederic
    Morvan, Claire
    Rolhion, Nathalie
    Martin-Verstraete, Isabelle
    [J]. NPJ BIOFILMS AND MICROBIOMES, 2024, 10 (01)
  • [10] Characteristics of Faecal Microbiota in Korean Patients with Clostridioides difficile-associated Diarrhea
    Jeon, Yong Duk
    Ann, Hea Won
    Lee, Woon Ji
    Kim, Jun Hyoung
    Seong, Hye
    Kim, Jung Ho
    Ahn, Jin Young
    Jeong, Su Jin
    Ku, Nam Su
    Yeom, Joon Sup
    Yong, Dongeun
    Lee, Kyungwon
    Choi, Jun Yong
    [J]. INFECTION AND CHEMOTHERAPY, 2019, 51 (04): : 365 - 375